Brief: RVL Completes Financial Restructuring

RVL Pharmaceuticals

27/11/2023 12:12

Nov 27 (Reuters) - RVL Pharmaceuticals PLC  RVLPQ.PK :
    * RVL COMPLETES FINANCIAL RESTRUCTURING
    * RVL PHARMACEUTICALS INC - IT AND ITS UNIT RVL PHARMACY,
LLC 
SUCCESSFULLY EMERGED FROM THEIR CHAPTER 11 CASES ON NOVEMBER 22
    * RVL PHARMACEUTICALS INC - REVITALID PHARMACEUTICAL CORP
CONCURRENTLY EMERGED FROM ITS CHAPTER 11 CASE, THOUGH WILL BE
WOUND DOWN UNDER PLAN
    * RVL PHARMACEUTICALS INC - WILL CONTINUE TO OPERATE AND BE
SUPPORTED AS A PRIVATELY HELD COMPANY UNDER OWNERSHIP OF
ATHYRIUM
    * RVL PHARMACEUTICALS INC - PLAN WAS UNANIMOUSLY SUPPORTED
BY RVL
SUBSIDIARIES' SOLE SECURED LENDER AND OTHER KEY STAKEHOLDERS
    * RVL PHARMACEUTICALS INC - RVL PHARMACEUTICALS PLC ORDINARY
SHARES EXPECTED TO BE CANCELLED IN 2024
    * RVL PHARMACEUTICALS INC - ATHYRIUM PROVIDES CAPITAL TO
SUPPORT
LONG-TERM GROWTH,EXCHANGES OUTSTANDING DEBT INTO EQUITY OF
CERTAIN REORGANIZED ENTITIES

Source text for Eikon:  ID:nGNXc6XPZ8 
Further company coverage:  RVLPQ.PK 

 ((Reuters.Briefs@thomsonreuters.com;))